Managing depression and anxiety in the elderly population can be challenging due to the presence of multiple comorbidities. Learning pearls about psychiatry medication options can facilitate better pharmacologic selection and lessen risks for adverse side effects.  Objectives include:  

1. Identify how Social Determinants of Health impact our geriatric population.
2. Recognize depression and anxiety in the geriatric population and describe some screeners commonly used.
3. Discuss how to choose a psychotropic medication by reviewing the benefits and risks of various commonly used pharmacological agents.
4. Review pertinent labs and tests that may be necessary when treating this population.

Case study discussion of differences between PTSD, complex PTSD and developmental trauma and the intricacies of optimal treatment approaches. Objectives include: 

1. Learner will be able to correctly identify and diagnose the difference between PTSD, complex PTSD and developmental traumas for optimal treatment and collaborative treatment approaches.
2. Be able to recognize and distinguish adverse child events as they relate to common psychiatric disorders such as oppositional defiance disorder (ODD), ADHD, major depressive disorder (MDD), anxiety disorders, impulsivity and conduct disorders (CD), substance use disorders and more. 
3. Identify populations at greatest risk for adverse childhood events; lower socio-economic, undereducated and single-parent family homes and/or gender-diverse, transgender individuals, ethnoracial minorities.

This lecture will explore the unique dynamics at play for child sexual abuse (CSA) Attendees will explore how PAs can be prepared to recognize risk for CSA, respond to a disclosure, and support victims and their families. As an Adverse Childhood Experience (ACE), CSA has the potential to negatively impact a child’s life well into adulthood. This lecture will explore the interplay between CSA and social determinants of health, and how PAs can promote prevention efforts.  Objectives include: 

1: Define child sexual abuse (CSA).

2. Discuss how child sexual abuse differs from sexual assault.

3. Explain how and why children disclose or fail to disclose CSA.

4. Explain how to respond to a child's disclosure.

5. Identify social determinants of health that are related to an increased risk of CSA.

Cancer health disparities persist in both cancer incidence and outcome. Multiple factors contribute, including socioeconomic, socio-environmental, behavioral, and biological. Additionally, increasing amounts of evidence underscore the contribution of comorbidities, chronic social stress, and even the microbiome may contribute to health disparities in cancer risk and survival.  In this lecture we will examine disparities and associated factors in the most common cancer types (breast, prostate, lung and colon).  Cancer treatment outcomes, enrollment in clinical trials, and quality of life among cancer survivors will also be discussed thru the lens of health equity.  Finally, we will focus on the role that advanced practice providers can have in addressing cancer health disparities regardless of specialty.  This session is best suited for all patient facing practitioners and those who participate in clinical research.  Objectives include: 

1. Develop increased awareness of the disparities that exist regarding the diagnosis, treatment, and outcome of common cancer types.
2. Explain how the lack of participation in clinical trials has created barriers to effective treatment for diverse/minority populations. 
3. Appreciate that racial and ethnic minority cancer survivors experience a disproportionate burden of the adverse effects of cancer and cancer treatment.  
4. Devise at least one actionable task they can take in their own practice to address the structural, environmental, or institutional factors that contribute to cancer health disparities.

Effective and timely ways to address, screen, treat and code for substance use disorder in primary care medicine.  You will hear about how my family was personally affected by substance use disorder (SUD). Objectives include:

1. Recognize health disparities when treating substance use disorder. 
2. Illustrate effective ways to talk to your patients and patient's families about substance use disorder.
3. Apply the current and readily available screening tools in your practice.
4. Demonstrate how to appropriately treat patients with SUD beyond the need for a DEA(x) number and applying the appropriate ICD-10 codes.
5. Identify ways to reduce SUD stigma in patient assessment and care.